Stability of Pharmaceutical Cocrystal During Milling: A Case Study of 1:1 Caffeine-Glutaric Acid

被引:29
作者
Chow, Pui Shan [1 ]
Lau, Grace [1 ]
Ng, Wai Kiong [1 ]
Vangala, Venu R. [1 ]
机构
[1] ASTAR, Crystallisat & Particle Sci, Inst Chem & Engn Sci, 1,Pesek Rd, Singapore 627833, Singapore
关键词
PROCESS-INDUCED DISORDER; X-RAY-DIFFRACTION; CO-CRYSTALS; QUANTITATIVE-DETERMINATION; PHYSICOCHEMICAL PROPERTIES; TRANSFORMATION; GRISEOFULVIN; DRUG; FORM; PHARMACOKINETICS;
D O I
10.1021/acs.cgd.6b01160
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Despite the rising interest in pharmaceutical cocrystals in the past decade, there is a lack of research on the solid processing of cocrystals downstream to crystallization. Mechanical stress induced by unit operations such as milling could affect the integrity of the material. The purpose of this study is to investigate the effect of milling on pharmaceutical cocrystals and to compare the performance of ball mill and jet mill, using caffeine glutaric acid (1:1) cocrystal as the model compound. Our results show that ball milling induced polymorphic transformation from the stable Form II to the metastable Form I, whereas Form II remained intact after jet milling. Jet milling was found to be effective in reducing particle size, but ball milling was unable to reduce the particle size beyond a certain limit even with increasing milling intensity. The heating effect during ball milling was proposed as a possible explanation for the difference in the performance of the two types of mill. The local increase in temperature beyond the polymorphic transformation temperature may lead to the conversion from stable to metastable form. At longer ball milling duration, the local temperature could exceed the melting point of Form I, leading to surface melting and subsequent recrystallization of Form I from the melt and agglomeration of the crystals. The findings in this study have broader implications on the selection of mill and interpretation of milling results for not only pharmaceutical cocrystals but pharmaceutical compounds in general.
引用
收藏
页码:4064 / 4071
页数:8
相关论文
共 48 条
[1]   Polymorphism in cocrystals: a review and assessment of its significance [J].
Aitipamula, Srinivasulu ;
Chow, Pui Shan ;
Tan, Reginald B. H. .
CRYSTENGCOMM, 2014, 16 (17) :3451-3465
[2]   Cocrystal Hydrate of an Antifungal Drug, Griseofulvin, with Promising Physicochemical Properties [J].
Aitipamula, Srinivasulu ;
Vangala, Venu R. ;
Chow, Pui Shan ;
Tan, Reginald B. H. .
CRYSTAL GROWTH & DESIGN, 2012, 12 (12) :5858-5863
[3]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[4]   The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics [J].
Bak, Annette ;
Gore, Anu ;
Yanez, Evelyn ;
Stanton, Mary ;
Tufekcic, Sunita ;
Syed, Rashid ;
Akrami, Anna ;
Rose, Mark ;
Surapaneni, Sekhar ;
Bostick, Tracy ;
King, Anthony ;
Neervannan, Sesha ;
Ostovic, Drazen ;
Koparkar, Arun .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (09) :3942-3956
[5]  
Balaz P., 2008, MECHANOCHEMISTRY NAN, P122
[6]   Pharmaceutical cocrystal and salts of norfloxacin [J].
Basavoju, Srinivas ;
Bostrom, Dan ;
Velaga, Sitaram P. .
CRYSTAL GROWTH & DESIGN, 2006, 6 (12) :2699-2708
[8]   Celecoxib cocrystal polymorphs with cyclic amides: synthons of a sulfonamide drug with carboxamide coformers [J].
Bolla, Geetha ;
Mittapalli, Sudhir ;
Nangia, Ashwini .
CRYSTENGCOMM, 2014, 16 (01) :24-27
[9]   Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1 [J].
Chieng, N. ;
Zujovic, Z. ;
Bowmaker, G. ;
Rades, T. ;
Saville, D. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 327 (1-2) :36-44
[10]   Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process [J].
Chun, Nan-Hee ;
Wang, In-Chun ;
Lee, Min-Jeong ;
Jung, Yun-Taek ;
Lee, Sangkil ;
Kim, Woo-Sik ;
Choi, Guang J. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :854-861